Repeated transfusions of autologous cytokine-induced killer cells for treatment of haematological malignancies in elderly patients: a pilot clinical trial.

Yang, Bo

Repeated transfusions of autologous cytokine-induced killer cells for treatment of haematological malignancies in elderly patients: a pilot clinical trial. [electronic resource] - Hematological oncology Sep 2012 - 115-22 p. digital

Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

1099-1069

10.1002/hon.1012 doi


Aged
Aged, 80 and over
Antibodies, Monoclonal--therapeutic use
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Biomarkers, Tumor
Cells, Cultured--drug effects
Comorbidity
Cytokine-Induced Killer Cells--transplantation
Female
Hematologic Neoplasms--drug therapy
Humans
Immunotherapy, Adoptive
Interferon-gamma--pharmacology
Interleukin-2--pharmacology
L-Lactate Dehydrogenase--blood
Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy
Lymphoma, Non-Hodgkin--drug therapy
Male
Middle Aged
Multiple Myeloma--drug therapy
Myelodysplastic Syndromes--drug therapy
Pilot Projects
Recombinant Proteins--pharmacology
Remission Induction
Salvage Therapy
Thymopentin--pharmacology
Treatment Outcome
beta 2-Microglobulin--analysis